KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $244 | +24.5% | 14,026 | +0.7% | 0.00% | – |
| Q2 2023 | $196 | +30.7% | 13,928 | -0.3% | 0.00% | – |
| Q1 2023 | $150 | -54.3% | 13,974 | -36.1% | 0.00% | – |
| Q4 2022 | $328 | -99.9% | 21,874 | -0.0% | 0.00% | – |
| Q3 2022 | $281,000 | +76.7% | 21,884 | +33.5% | 0.00% | – |
| Q2 2022 | $159,000 | -62.9% | 16,398 | -61.9% | 0.00% | – |
| Q1 2022 | $428,000 | +6.2% | 43,094 | +25.7% | 0.00% | – |
| Q4 2021 | $403,000 | +84.9% | 34,277 | +79.1% | 0.00% | – |
| Q3 2021 | $218,000 | -36.3% | 19,134 | -22.0% | 0.00% | – |
| Q2 2021 | $342,000 | -24.0% | 24,522 | +0.9% | 0.00% | – |
| Q1 2021 | $450,000 | +4.9% | 24,300 | 0.0% | 0.00% | – |
| Q4 2020 | $429,000 | +58.9% | 24,300 | +38.1% | 0.00% | – |
| Q3 2020 | $270,000 | -39.7% | 17,600 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $448,000 | +112.3% | 17,600 | +29.4% | 0.00% | – |
| Q1 2020 | $211,000 | +40.7% | 13,600 | 0.0% | 0.00% | – |
| Q4 2019 | $150,000 | +29.3% | 13,600 | 0.0% | 0.00% | – |
| Q3 2019 | $116,000 | -37.0% | 13,600 | 0.0% | 0.00% | – |
| Q2 2019 | $184,000 | +166.7% | 13,600 | +257.9% | 0.00% | – |
| Q1 2019 | $69,000 | -35.5% | 3,800 | 0.0% | 0.00% | – |
| Q4 2018 | $107,000 | – | 3,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |